Article info
PDFOriginal research
Ethical examination of deep brain stimulation’s ‘last resort’ status
- Correspondence to Ian Stevens, Philosophy & Gender Studies, University of Tasmania School of Humanities, Hobart, TAS 7001, Australia; Ian.Stevens{at}utas.edu.au
Citation
Ethical examination of deep brain stimulation’s ‘last resort’ status
Publication history
- Received June 18, 2020
- Revised October 26, 2020
- Accepted November 1, 2020
- First published January 13, 2021.
Online issue publication
November 29, 2021
Article Versions
- Previous version (13 January 2021).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.
Other content recommended for you
- Deep brain stimulation: practical insights and common queries
- Driving restrictions following deep brain stimulation surgery
- Paediatric deep brain stimulation: ethical considerations in malignant Tourette syndrome
- The burden of normality: from ‘chronically ill’ to ‘symptom free’. New ethical challenges for deep brain stimulation postoperative treatment
- Cognitive declines following bilateral subthalamic nucleus deep brain stimulation for the treatment of Parkinson’s disease
- Approaches to neuromodulation for schizophrenia
- Outcomes from stereotactic surgery for essential tremor
- Suicide ideation and behaviours after STN and GPi DBS surgery for Parkinson’s disease: results from a randomised, controlled trial
- Deep brain stimulation: a return journey from psychiatry to neurology
- Charting the road forward in psychiatric neurosurgery: proceedings of the 2016 American Society for Stereotactic and Functional Neurosurgery workshop on neuromodulation for psychiatric disorders